National Cancer Institute; Amended Notice of Meeting

---
identifier: "/us/fr/2022-00258"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Cancer Institute; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2022-00258"
section_name: "National Cancer Institute; Amended Notice of Meeting"
positive_law: false
currency: "2022-01-11"
last_updated: "2022-01-11"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2022-00258"
document_type: "notice"
publication_date: "2022-01-11"
agencies:
  - "Health and Human Services Department"
  - "National Institutes of Health"
fr_citation: "87 FR 1426"
fr_volume: 87
---


#  National Cancer Institute; Amended Notice of Meeting

Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, Translational and Basic Research Early Lesions (U54 and U24), March 02, 2022, 09:00 a.m. to March 03, 2022, 06:00 p.m., National Cancer Institute at Shady Grove, Room 7W108, 9609 Medical Center Drive, Rockville, Maryland 20850 which was published in the *Federal Register* on December 20, 2021, FR Doc 2021-27482, 86 FR 71902.

This notice is being amended to change the meeting date from March 2-3, 2022 to March 15-16, 2022. The meeting times and location will stay the same. The meeting is closed to the public.

Dated: January 5, 2022.

David W. Freeman,

Program Analyst, Office of Federal Advisory Committee Policy.